Figure 2 | Scientific Reports

Figure 2

From: Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs

Figure 2The alternative text for this image may have been generated using AI.

Changes in the T lymphocyte subset and plasma cytokines in peripheral blood after low-dose CY + ET treatment. (A) Changes in peripheral blood lymphoid subgroups before and after low-dose CY + ET treatment. (B) Changes in peripheral blood cytokines before and after low-dose CY + ET treatment.

Back to article page